Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFragrant Prosp. Regulatory News (FPP)

Share Price Information for Fragrant Prosp. (FPP)

Share Price is delayed by 15 minutes
Get Live Data
0.405    -0.01 (-2.41%)
Bid:
0.38
Ask:
0.43
Spread: 0.05 (13.158%)
Market Cap: £1.03m
FPP Live PriceLast checked at - London Stock Exchange

Intraday Fragrant Prosp. Share Chart

Amendment: New CLN Issued

17 Apr 2025 08:26

RNS Number : 4491F
Fragrant Prosperity Holdings Ltd
17 April 2025
 

 

For immediate release 17 April 2025

 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. 

 

Fragrant Prosperity Holdings Limited

("FPP" or the "Company")

Issue of New Convertible Loan Note

 

The below announcement replaces that issued earlier this morning to amend a typo in the date in point (i) from 31 December 2015 to 31 December 2025. Everything else in the announcement remains unaltered

 

Fragrant Prosperity Holdings Limited (the "Company"), announces it has issued convertible loan notes for £125,000 and the refinancing of existing convertible loans notes.

 

Issue of Convertible Loan Notes

 

The Company has created a new convertible loan note instruments of up to a maximum of £200,000. Notes issued under this instrument ("Notes") carry an interest rate of 5% per annum, which is to be rolled up and added to principal quarterly until the earlier of conversion or repayment of the relevant Notes. The Notes must be repaid as a bullet payment on the second anniversary of issue but Company has an option to repay the Notes at any time after the earlier of (i) 31 December 2025 and (ii) the Company has announced it has agreed the key commercial term of a reverse takeover of the Company under the UK Listing Rules.

 

Conversion of the Notes into equity becomes unconditional upon the publication of a Prospectus for a fund raise over and above the 19.99% permitted in any 12 month period without the issuance of a Prospectus. The Notes upon conversion convert into ordinary shares of the Company ("Shares") at a 10% discount to the price of a fundraise undertaken by the Company alongside the issuance of a Prospectus issued under the UK Prospectus Regulation Rules (or any successor legislation or rules). Pursuant to the subscription agreements for the Notes the Company provided a number of warranties and undertakings in respect of the Company to the investors.

 

Issue of Warrants

 

Holders of the Notes will receive 1 warrant for every share received at the placing price of the relevant Qualifying Fundraise, should the Notes automatically convert into shares upon the publication of a prospectus for a qualifying equity raise.

 

Refinancing of existing convertible loan notes

 

The Company has reached agreements with the holders of its existing convertible loan notes representing £400,000 of the total issued of £515,000 or 78% to enter into a stand still arrangement as follows:

 

· Holders agree to a stand still arrangement to preventing enforcement action until 3 September 25;

· All past accrued interest to be waived

· No applicable future interest should conversion happen prior to the end of the stand still period

· Repayment of 75% of the original principle amount advanced from the proceeds of the Note issue; and

· Automatic conversion into equity of sums owed under the loan note at the placing price upon Qualifying Fundraise of a minimum of £250,000

· Agree to a standard form lock in prohibiting the disposal of any shares received under the conversion until the earlier of 12 months from date of conversion or 6 months following the completion of a reverse take over by the Company

 

Use of proceeds

 

The Company intends to use the proceeds to repay an existing convertible loan note holder which alongside the refinancing of the remained of the existing convertible loan notes as noted above, would result in a significantly improved and recapitalised balance sheet with no other convertible loan notes in existence.

 

Related party transaction

 

Of the £125,000 Notes that have been issued, £25,000 have been subscribed for by Stonedale Management & Investments Ltd a company controlled by Simon Retter a Director of the Company.

 

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement this information is considered to be in the public domain.

 

ENDS

 

  

Fragrant Prosperity Holdings Limited

+44 (0) 20 3137 1902

FPP Broker: Optiva Securities Vishal Balasingham

+44 (0) 20 3137 1903

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODDDLBFEZLLBBL
Date   Source Headline
29th Mar 20219:00 amRNSPrice Monitoring Extension
29th Mar 20217:00 amRNSAppointment of Director
17th Mar 20212:05 pmRNSSecond Price Monitoring Extn
17th Mar 20212:00 pmRNSPrice Monitoring Extension
2nd Mar 202111:05 amRNSSecond Price Monitoring Extn
2nd Mar 202111:00 amRNSPrice Monitoring Extension
2nd Mar 20219:05 amRNSSecond Price Monitoring Extn
2nd Mar 20219:00 amRNSPrice Monitoring Extension
1st Mar 20214:40 pmRNSSecond Price Monitoring Extn
1st Mar 20214:35 pmRNSPrice Monitoring Extension
1st Mar 20219:05 amRNSSecond Price Monitoring Extn
1st Mar 20219:00 amRNSPrice Monitoring Extension
1st Mar 20217:00 amRNSEquity Fundraise
26th Feb 20219:06 amRNSSecond Price Monitoring Extn
26th Feb 20219:00 amRNSPrice Monitoring Extension
24th Feb 20217:00 amRNSExpansion of investment mandate
12th Feb 20214:40 pmRNSSecond Price Monitoring Extn
12th Feb 20214:35 pmRNSPrice Monitoring Extension
9th Feb 20214:41 pmRNSSecond Price Monitoring Extn
9th Feb 20214:35 pmRNSPrice Monitoring Extension
9th Feb 20212:06 pmRNSSecond Price Monitoring Extn
9th Feb 20212:01 pmRNSPrice Monitoring Extension
12th Jan 20217:00 amRNSHalf-year Report
17th Aug 20207:50 amRNSAnnual Financial Report
8th Jun 20207:50 amRNSConvertible Loan Notes and grant of Options
20th Dec 20197:00 amRNSResult of AGM
16th Dec 20197:00 amRNSIssue of Convertible Loan Notes&Change of Director
25th Nov 20198:34 amRNSHalf-year Report
21st Nov 20197:00 amRNSNotice of AGM
15th Nov 20199:23 amRNSDirectorate Change
12th Nov 20197:00 amRNSAnnual Financial Report
15th Jul 20199:20 amRNSIssue of Equity
17th Jun 20199:07 amRNSIssue of Equity
13th Jun 20199:39 amRNSDirectorate Change
14th Jan 20198:02 amRNSHalf-year Report
1st Oct 20188:57 amRNSResult of AGM
29th Aug 201810:16 amRNSNotice of AGM
21st Aug 20189:57 amRNSFinal Results
15th Aug 20187:20 amRNSHolding(s) in Company
4th Jul 20187:46 amRNSDirectorate Change
28th Mar 201810:52 amRNSDirectorate Change
15th Jan 20181:42 pmRNSHolding(s) in Company - Replacement
15th Jan 20181:40 pmRNSHolding(s) in Company
12th Jan 20182:11 pmRNSHolding(s) in Company
12th Jan 20182:10 pmRNSHolding(s) in Company
12th Jan 20182:06 pmRNSHolding(s) in Company
21st Dec 20177:00 amRNSHalf-year Report
11th Dec 20175:02 pmRNSChange of Name
31st Oct 20177:00 amRNSDirectorate Change
6th Oct 20177:00 amRNSChange of Directors

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.